ERBB2 and breast cancer: In addition, in the breast cancer subtypes according to the prediction analysis of microarray 50 (PAM50) [15], luminal A subtype showed the highest GPD1 mRNA level compared with luminal B, HER2-enriched and basal-like subtypes (Figure 1G–1H).